Abstract 345P
Background
While induction with cytarabine containing immuno-chemotherapy is recommended for fit patients (pts) with newly diagnosed mantle cell lymphoma (MCL), the choice of accompanying platinum agent is less clear. Substitution to carboplatin simplifies chemotherapy administration and reduces nephrotoxicity. We aimed to assess the impact of up to 6 cycles of alternating RCHOP/RDHAC (carboplatin) as induction for transplant-eligible pts with MCL prior to BEAM autologous stem cell transplant (ASCT).
Methods
Single centre retrospective cohort study [2008-2023] of pts who commenced RCHOP/RDHAC for MCL. Descriptive statistics, Kaplan-Meier survival analysis, impact of baseline variables tested, and nephrotoxicity graded by CTCAE v5.
Results
Of 36 pts identified, 34 completed intended therapy. Median age was 63 yrs (range 37-76), 32 males (89%), stage 4=28 (78%), MIPI low 33%/int 47%/high 19%, aggressive morphology=19%, p53=90% (9/10) and high Ki67=63% (15/24). Mean induction relative dose intensity was 99% (SD 5%). Autograft was performed in 26 pts; insufficient stem cell collection in 1 patient. Response was evaluable by PET/CT prior to autograft in 31 pts; not assessed in 5 pts: 25 complete response, 5 partial response and 1 progressive disease (ORR 97%). By Jun 2023, with median (m) follow-up of 85 mo: 16 pts died, 12 relapsed; mPFS 90 mo and mOS 112 mo; mOS following relapse/progression 16 mo despite bruton tyrosine kinase inhibitor use in 7 pts (54%). Nephrotoxicity with induction was uncommon (Table); 1 pt required dialysis in setting of organ failure associated with sepsis. Median admission duration per pt for induction therapy was 5 days (IQR, 0-9.5). Table: 345P
Table: 345P Adverse events
No. pts | |
Creatinine increase- Grade 1/2- Grade 3/4 | 8 (22%)1 (3%) |
Acute kidney injuryˆ- Grade 3- Grade 4 | 1 (3%)1 (3%) |
Febrile neutropenia | 9 (25%) |
Transplant-related mortality* | 3 (8%) |
ˆincludes 1 pt with sepsis during stem cell mobilization with RDHAC; 1 pt with acute on chronic renal impairment with RCHOP*includes 1 pt with sepsis during stem cell mobilization with RDHAC
Conclusions
This retrospective analysis is one of the largest cohorts of RCHOP/RDHAC reported in MCL. Low rates of clinically relevant nephrotoxicity with comparable long-term outcomes highlight carboplatin substitution as an option in selected pts. Survival after relapse remains poor.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
373P - Investigating the impact of treatment on geriatric patients with locally advanced head and neck squamous cell carcinoma
Presenter: Yen Ting Liu
Session: Poster Display
Resources:
Abstract
374P - Immunohistochemical evaluation of oral lichen planus: A prospective clinical study
Presenter: Saravanan Sampoornam Pape
Session: Poster Display
Resources:
Abstract
375P - Survival and prognostic factors of head and neck squamous cell carcinoma patients treated with either definitive CCRT or post operative CCRT with platinum-based chemotherapy in Rajavithi hospital, Thailand
Presenter: wanit samadee
Session: Poster Display
Resources:
Abstract
376P - Nutrition as an independent prognostic factor in locally advanced nasopharyngeal carcinoma: A retrospective cohort study and propensity score-matched analysis
Presenter: haizhen yi
Session: Poster Display
Resources:
Abstract
377P - Oropharyngeal squamous cell carcinomas in Indian population: P16 positivity and treatment outcomes following chemoradiotherapy
Presenter: Parth Verma
Session: Poster Display
Resources:
Abstract
378P - A real-world retrospective analysis of the efficacy of pembrolizumab combined with chemotherapy as neoadjuvant treatment for locally advanced head and neck squamous cell carcinoma (LA HNSCC)
Presenter: zhu Liu
Session: Poster Display
Resources:
Abstract
379P - Nimotuzumab in combination with chemoradiation for patients with intermediate stage and locally advanced nasopharyngeal carcinoma: A retrospective comparative analysis using 5-year real-world survival data
Presenter: Andhika Rachman
Session: Poster Display
Resources:
Abstract
380P - An epidemiological analysis on the prevalence of oral cancer and its awareness among Irula tribes of South India
Presenter: Delfin Lovelina Francis
Session: Poster Display
Resources:
Abstract
381P - P16INK4 over-expression, early stages, keratinization, and surgical margin-free status are associated with better prognosis of oral squamous cell carcinoma (OSCC)
Presenter: Sumadi Lukman Anwar
Session: Poster Display
Resources:
Abstract
382P - Oral health disparities in privileged and underprivileged tribes of south India: A study of the prevalence of precancerous oral lesions
Presenter: Shanavas Palliyal
Session: Poster Display
Resources:
Abstract